MicroRNAs (miRNA) are short (∼ 22 nucleotides) non-coding RNA molecules that regulate
gene expression at the post-transcriptional level. Their expression is specific to cells and …

Recognition that breast cancer is a heterogeneous disease in which each patient's tumor
has specific characteristics has led to a search for biomarkers and combinations of markers …

In addition to their potential as tissue-based markers for cancer classification and
prognostication, the study of microRNAs (miRNAs) in blood circulation is also of interest. In …

BACKGROUND Repeated implantation failure (RIF) is a major problem encountered in IVF.
We have previously reported that RIF-IVF patients have a different endometrial gene …

Cancer represents a complex group of heterogeneous diseases. While many cancers share
fundamental biological processes (hallmarks of cancer) necessary for their development …

MicroRNAs (miRNAs) are small, noncoding RNA molecules with the ability to
posttranscriptionally regulate gene expression via targeting the 3′ untranslated region of …

Introduction Serum microRNAs have the potential to be valuable biomarkers of cancer. This
investigation addresses two issues that impact their utility: a) appropriate normalization …

Micro-RNAs (miRs) are important regulators of mRNA and protein expression; the ability of
miR expression profilings to distinguish different cancer types and classify their sub-types …

Novel cancer biomarker discovery is urgently needed for cancer theragnosis and prognosis,
and among the many possible types of samples, blood is regarded to be ideal for this …

Digestive cancers (eg, gastric, colorectal, pancreatic or hepatocarcinoma) are among the
most frequently reported cancers in the world, and are characterized by invasivity, metastatic …